Mission Statement, Vision, & Core Values (2026) of Tong Ren Tang Technologies Co. Ltd.

Step into the enduring legacy of Tong Ren Tang Technologies Co. Ltd. (1666.HK), a company rooted in tradition since 1669 and carrying over 350 years of expertise into today's healthcare landscape; with a market capitalization of approximately HKD 6.03 billion as of December 2025, its mission-'Cultivating Kind-heartedness and Benefiting Mankind and Preserving Health'-drives a values-led approach that balances ethical practice with commercial success, while a forward-looking vision to become an integrated Chinese medicine and biological pharmaceutical group emphasizes technology, production, services and trading to modernize and internationalize traditional Chinese medicine; integrity, innovation, quality, sustainability and customer-centricity anchor its strategy across herbal medicines, healthcare products and cosmetics through technology services, development and consultancy, inviting a closer look at how centuries-old principles translate into measurable, modern impact.

Tong Ren Tang Technologies Co. Ltd. (1666.HK) - Intro

• Established: 1669 (heritage brand lineage)
• Listing: Hong Kong (Ticker: 1666.HK)
• Market capitalization (Dec 2025): ~HKD 6.03 billion
• Core product categories: herbal medicines, health supplements, TCM cosmetics
• Operational segments: technology services, product development, consultancy and distribution

• Preserve and transmit classical TCM knowledge while applying modern R&D and manufacturing standards.
• Deliver safe, effective, and standardized TCM products to domestic and international consumers.
• Enable evidence-based integration of TCM into broader healthcare systems.

• Be a leading global ambassador for Chinese medicine through innovation, quality assurance, and international market expansion.
• Fuse centuries-old clinical tradition with modern technology to create scalable healthcare solutions.

• Heritage and authenticity - honoring provenance and classical prescriptions.
• Scientific rigor - investing in R&D, quality control and regulatory compliance.
• Patient-centered safety - prioritizing efficacy, standardization and traceability.
• International openness - adapting formulations and certifications to global markets.
• Collaboration - working with healthcare institutions, research centers and policy frameworks to mainstream TCM.

• R&D & standardization: expansion of laboratory and clinical research capabilities to support product registration in new jurisdictions.
• Supply-chain traceability: implementation of digital tracking and quality assurance systems across herb sourcing and processing.
• Market penetration: targeted growth in Southeast Asia, Greater China, and select Western markets aligned with export and regulatory milestones.
• Brand modernization: development of consumer-facing healthcare and cosmetics lines that blend TCM formulations with contemporary packaging and channels.

Tong Ren Tang Technologies Co. Ltd. (1666.HK) - Overview

• The mission emphasizes improving and enhancing people's health and quality of life through trusted traditional Chinese medicine (TCM) innovation and service.
• It commits the company to balancing commercial success with ethical practice - 'performing good deeds along with making profits' - and to preserving both mental tranquillity and physical wellness for customers and communities.
• Over centuries, this mission has shaped strategic decisions: product development, clinical quality standards, retail expansion, and community-health programs.
• The focus on 'Kind-heartedness' and 'Benefiting Mankind' underlines a long-standing corporate social responsibility approach that informs charitable initiatives, accessibility of care and patient-first product policies.

• Strategic implications: mission-driven positioning supports premium branding, customer loyalty and resilience in regulated healthcare markets.
• Operational focus: quality control, standardized production, clinic and pharmacy integration, and research partnerships to modernize TCM while honoring traditional practices.
• Stakeholder alignment: employees, suppliers, healthcare professionals and investors are engaged through programs that connect commercial outcomes to social and health impact.

Tong Ren Tang Technologies Co. Ltd. (1666.HK) - Mission Statement

• Core mission: modernize and industrialize TCM through R&D, high-standard manufacturing, and service-led healthcare delivery.
• Strategic pillars: integrate biotechnology with traditional formulations, scale GMP-compliant production, expand patient- and consumer-facing services, and broaden trading and export channels.
• Alignment with national strategy: supports Healthy China initiatives and internationalization of TCM exports.

• Technology: sustained R&D investment (3%+ of revenue in 2023), clinical collaborations for evidence-based TCM products, and biotech platform development for proprietary extracts and APIs.
• Production: expansion of GMP-certified facilities, vertical integration of key herb processing, and automation to improve yield and quality control (target defect rates <0.5%).
• Services: roll-out of patient-facing clinics, digital health platforms, and pharmacy networks to increase recurring revenue and patient retention.
• Trading: strengthening domestic distribution while growing export share (targeting 15-20% of revenue from overseas markets over medium term).

• Investors: predictable margin profile from integrated production and trading; growth supported by rising R&D intensity and export expansion.
• Patients/consumers: improved quality control and evidence-backed TCM offerings, greater access via clinics and digital services.
• Regulators/partners: adherence to GMP, clinical trial standards and alignment with national Healthy China policies to facilitate approvals and market access.

Tong Ren Tang Technologies Co. Ltd. (1666.HK) - Vision Statement

• Heritage-led innovation: preserve TCM legacy while scaling evidence-based modernization.
• Global accessibility: expand presence so classic TCM formulations and new therapeutics reach international markets.
• Trusted quality and safety: set industry benchmarks for GMP-compliant production, traceability and clinical validation.
• Health-tech integration: leverage digital health, R&D and smart manufacturing to enhance outcomes and customer experience.

• To protect and modernize the Tong Ren Tang legacy by delivering high-quality, scientifically validated TCM products and services that improve population health, respect nature, and sustain trust among patients, partners and investors.

• Integrity stands at the forefront of Tong Ren Tang Technologies Co. Ltd.'s core values. This principle underlies the company's commitment to ethical practices and transparency, promoting trust among stakeholders.
• Operational examples: full product traceability systems across suppliers, adherence to national pharmacopoeia standards and regular third‑party audits.

• Innovation is at the heart of Tong Ren Tang's strategies, driving its growth and product development.
• R&D focus: combination of traditional formulations with modern extraction, standardization and clinical trial methods; investment in R&D centers and collaborations with academic institutions.

• Quality is a non-negotiable value for Tong Ren Tang, reflected in its rigorous quality control processes.
• Quality systems include Good Manufacturing Practice (GMP) facilities, batch-level quality testing, and digital quality records to reduce recalls and ensure product consistency.

• Sustainability reflects Tong Ren Tang's dedication to environmental responsibility and sustainable business practices.
• Practices: sustainable sourcing of herbal materials, water and energy efficiency in manufacturing, and community programs to support cultivar conservation.

• A customer-centric approach is essential to Tong Ren Tang's operational philosophy.
• Initiatives: personalized healthcare services, TCM consultation platforms, loyalty programs and multi-channel retailing that tie clinical guidance to product fulfilment.

• Enhance clinical evidence: expand randomized controlled trials and observational research to validate efficacy and safety across core products.
• Scale sustainable sourcing: increase certified sustainable herb procurement and invest in cultivation partnerships to secure supply and biodiversity.
• Digital transformation: deploy telehealth, e-commerce and CRM enhancements to raise customer retention and personalize care.
• Governance and transparency: strengthen ESG reporting, publish product traceability data and maintain rigorous compliance to international standards.